Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Lallemant

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
The Journal of Infection|August 12, 2019
Long term renal function in Asian HIV-1 infected adults receiving tenofovir disoproxil fumarate without protease inhibitorsGeoffroy Liegeon, Linda Harrison, Anouar Nechba, et al.
Plos One|August 4, 2012
Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in ThailandWoottichai Khamduang, Catherine Gaudy-Graffin, Nicole Ngo-Giang-Huong, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2025
Single Doses of Pediatric Dolutegravir Dispersible Tablets in Neonates Support Multidosing: PETITE-Dolutegravir StudyTim R Cressey, Nicolas Salvadori, Helena Rabie, et al.
The Journal of Infectious Diseases|May 3, 2006
Revisiting the role of neutralizing antibodies in mother-to-child transmission of HIV-1Francis Barin, Gonzague Jourdain, Sylvie Brunet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2013
Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant womenWoottichai Khamduang, Nicole Ngo-Giang-Huong, Catherine Gaudy-Graffin, et al.
The Journal of Antimicrobial Chemotherapy|September 28, 2014
Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancyTim R Cressey, Saik Urien, Edmund V Capparelli, et al.
The Pediatric Infectious Disease Journal|July 31, 2015
Efavirenz Concentrations and Probability of HIV Replication in ChildrenNontiya Homkham, Tim R Cressey, Naïm Bouazza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2010
Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: a 5-year observational cohort studyIntira J Collins, Gonzague Jourdain, Rawiwan Hansudewechakul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2017
Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and FormulationsMartina Penazzato, Devasena Gnanashanmugam, Pablo Rojo, et al.
The Lancet. HIV|January 31, 2024
Paediatric abacavir-lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trialAdrie Bekker, Nicolas Salvadori, Helena Rabie, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
The Journal of Infection|August 12, 2019
Long term renal function in Asian HIV-1 infected adults receiving tenofovir disoproxil fumarate without protease inhibitorsGeoffroy Liegeon, Linda Harrison, Anouar Nechba, et al.
Plos One|August 4, 2012
Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in ThailandWoottichai Khamduang, Catherine Gaudy-Graffin, Nicole Ngo-Giang-Huong, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2025
Single Doses of Pediatric Dolutegravir Dispersible Tablets in Neonates Support Multidosing: PETITE-Dolutegravir StudyTim R Cressey, Nicolas Salvadori, Helena Rabie, et al.
The Journal of Infectious Diseases|May 3, 2006
Revisiting the role of neutralizing antibodies in mother-to-child transmission of HIV-1Francis Barin, Gonzague Jourdain, Sylvie Brunet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2013
Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant womenWoottichai Khamduang, Nicole Ngo-Giang-Huong, Catherine Gaudy-Graffin, et al.
The Journal of Antimicrobial Chemotherapy|September 28, 2014
Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancyTim R Cressey, Saik Urien, Edmund V Capparelli, et al.
The Pediatric Infectious Disease Journal|July 31, 2015
Efavirenz Concentrations and Probability of HIV Replication in ChildrenNontiya Homkham, Tim R Cressey, Naïm Bouazza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2010
Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: a 5-year observational cohort studyIntira J Collins, Gonzague Jourdain, Rawiwan Hansudewechakul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2017
Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and FormulationsMartina Penazzato, Devasena Gnanashanmugam, Pablo Rojo, et al.
The Lancet. HIV|January 31, 2024
Paediatric abacavir-lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trialAdrie Bekker, Nicolas Salvadori, Helena Rabie, et al.
Pageof 10